US Broker Ratings

Phreesia, Inc. (PHR) Stock Analysis: Unveiling a 137.73% Potential Upside in Healthcare SaaS

Phreesia, Inc. (NYSE: PHR), a prominent player in the health information services industry, is capturing investor attention with a remarkable potential upside of 137.73%. This intriguing..

Clover Health Investments (CLOV): Investor Outlook Amid 52.25% Potential Upside

Clover Health Investments, Corp. (CLOV), a prominent player in the healthcare plans sector, is attracting considerable attention from investors, especially with a potential upside of 52.25%..

PACS Group, Inc. (PACS)

⚠️ No article content returned.

..

Omnicell, Inc. (OMCL) Stock Analysis: 67% Potential Upside with Strong Buy Ratings

Omnicell, Inc. (OMCL), a leader in healthcare technology innovation, is capturing investor attention with its promising growth trajectory and substantial potential upside. With a market capitalization..

Apellis Pharmaceuticals, Inc. (APLS): Investor Outlook with a 90% Potential Upside

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is a compelling player in the biotechnology sector, offering investors a unique opportunity to engage in innovative healthcare solutions. With a..

Addus HomeCare Corporation (ADUS) Stock Analysis: Potential 40% Upside Amid Robust Growth

Investors looking for opportunities in the healthcare sector might want to turn their attention to Addus HomeCare Corporation (NASDAQ: ADUS), a noteworthy player in the medical..

Indivior Pharmaceuticals, Inc. (INDV) Stock Analysis: Impressive Potential with a 59% Upside

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) has been making waves in the healthcare sector, specifically within the realm of drug manufacturing for specialty and generic markets. With..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Exploring a 140% Upside Potential in Biotech

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) stands out in the biotechnology sector, offering investors a compelling opportunity with a potential upside of 140.56%. With a market capitalization..

Ascentage Pharma Group (AAPG) Stock Analysis: A Biotech with 120% Potential Upside

Ascentage Pharma Group International (AAPG) is capturing the attention of investors with its promising outlook in the biotechnology industry, particularly due to its potential upside of..

Evotec SE (EVO) Stock Analysis: Exploring a 120% Potential Upside Amidst Challenging Metrics

Evotec SE (EVO), a German-based drug discovery and development company, stands at a pivotal juncture in its financial trajectory. With a market capitalization of $852.63 million..

Ligand Pharmaceuticals (LGND) Stock Analysis: A Biotech Powerhouse with 22% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands as a formidable player in the biotechnology sector, captivating investor interest with its diverse portfolio of biopharmaceutical assets. Based in..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Unpacking the 252% Potential Upside for Investors

For investors with an eye on the biotechnology sector, ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) stands out as a compelling prospect. With a market capitalization of $761.61..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Analyst Optimism Points to Significant Upside Potential

Dyne Therapeutics, Inc. (NASDAQ: DYN) is making waves in the biotechnology sector with its ambitious pipeline targeting neuromuscular diseases. Operating from Waltham, Massachusetts, this clinical-stage company..

Sotera Health Company (SHC) Stock Analysis: 49.5% Potential Upside Captures Investor Attention

Sotera Health Company (NASDAQ: SHC) stands out in the healthcare sector with its innovative sterilization solutions and lab testing services. As a key player in the..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A Biotech Gem with 55.90% Potential Upside

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) presents an intriguing opportunity for investors keen on the biotechnology sector. With a current market cap of $2.76 billion, this healthcare..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A Biotech Gem with a 288% Upside Potential

Janux Therapeutics, Inc. (NASDAQ: JANX) is making waves in the biotech sector with its innovative approach to cancer treatment and promising financial outlook. Based in San..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Strong Revenue Growth and Analyst Confidence Highlight Investment Potential

LeMaitre Vascular, Inc. (NASDAQ: LMAT) stands out in the healthcare sector with a robust portfolio in the medical instruments and supplies industry. With a market capitalization..

Harmony Biosciences Holdings (HRMY) Stock Report: Analyzing the 52.17% Potential Upside for Investors

Harmony Biosciences Holdings Inc. (NASDAQ: HRMY), a key player in the biotechnology sector, has emerged as a compelling investment opportunity for those keen on the dynamic..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Unpacking the 100% Potential Upside

Alphatec Holdings, Inc. (NASDAQ: ATEC), a dynamic player in the healthcare sector, is making waves in the medical devices industry. With a focus on innovative technologies..

DENTSPLY SIRONA Inc. (XRAY) Investor Outlook: Unpacking a 25.96% Potential Upside

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the medical instruments and supplies industry, is drawing attention with its substantial potential upside of 25.96%. This..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds